APA

Gourgou-Bourgade S., Cameron D., Poortmans P., Asselain B., Azria D., Cardoso F., A'Hern R., Bliss J., Bogaerts J., Bonnefoi H., Brain E., Cardoso M. J., Chibaudel B., Coleman R., Cufer T., Dal Lago L., Dalenc F., De Azambuja E., Debled M., Delaloge S., Filleron T., Gligorov J., Gutowski M., Jacot W., Kirkove C., MacGrogan G., Michiels S., Negreiros I., Offersen B. V., Penault Llorca F., Pruneri G., Roche H., Russell N. S., Schmitt F., Servent V., Thürlimann B., Untch M., van der Hage J. A., van Tienhoven G., Wildiers H., Yarnold J., Bonnetain F., Mathoulin-Pélissier S., Bellera C. & Dabakuyo-Yonli T. S. (20160519). Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso M J, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen B V, Penault Llorca F, Pruneri G, Roche H, Russell N S, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage J A, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C and Dabakuyo-Yonli T S. 20160519. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Gourgou-Bourgade S., Cameron D., Poortmans P., Asselain B., Azria D., Cardoso F., A'Hern R., Bliss J., Bogaerts J., Bonnefoi H., Brain E., Cardoso M. J., Chibaudel B., Coleman R., Cufer T., Dal Lago L., Dalenc F., De Azambuja E., Debled M., Delaloge S., Filleron T., Gligorov J., Gutowski M., Jacot W., Kirkove C., MacGrogan G., Michiels S., Negreiros I., Offersen B. V., Penault Llorca F., Pruneri G., Roche H., Russell N. S., Schmitt F., Servent V., Thürlimann B., Untch M., van der Hage J. A., van Tienhoven G., Wildiers H., Yarnold J., Bonnetain F., Mathoulin-Pélissier S., Bellera C. and Dabakuyo-Yonli T. S. (20160519). Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso M J, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen B V, Penault Llorca F, Pruneri G, Roche H, Russell N S, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage J A, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C and Dabakuyo-Yonli T S. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. : Annals of oncology : official journal of the European Society for Medical Oncology. 20160519.